TABLE 1.
Effect | Force | Cell Type and Response Time |
Significance | Reference Number |
---|---|---|---|---|
K+ channel activation, hyperpolarization (Whole cell recording) |
LSS; 0.2–16.5 dyn/cm2 | BAEC; s | Related to vasorelaxation | 51, 163, 271 |
Rb+ efflux stimulated | LSS, 1–10 dyn/cm2 | PAEC | Graded transient increase of K+ permeability |
6 |
Hyperpolarization (Vm-sensitive dyes) | LSS; 10–120 dyn/cm2 | BPAEC; steady state at 60 s |
As above | 250 |
Activation of nonselective cation channels (membrane patch) |
Suction (pressure, stretch); 10–20 mmHg |
PAEC; ms | Endothelial stretch-activated channels |
190 |
Intracellular Ca2+ rise (fluo 3) | Mechanical poking and dimpling |
HUVEC; s | Stretch-activated Ca2+ channels; depolarization. |
115 |
Large increase in release of NO | LSS; 8 dyn/cm2 | BAEC; s | Flow-mediated vasorelaxation |
51, 96, 258, 262, 364, 375, 376 |
Release of ATP, acetylcholine, endothelin, and substance P |
Flow through microcarrier bed | HUVEC; s | Neurotransmitter release | 26, 27, 237, 294 |
Stimulation of PA and PE hydrolysis | LSS; 1.4 and 22 dyn/cm2 | HUVEC; 10–30 s | Additional sources of AA; implies activation of PLA2 |
22 |
Decrease of intracellular pH | LSS; 0.5–13.4 dyn/cm2 | BAEC | Modulation of ionic balance | 406 |
Transient elevation of IP3; biphasic (BAEC) |
LSS; 30 and 60 dyn/cm2; cyclic stretch |
BAEC, HUVEC; >15– 30 s; major peak at 5 min (BAEC) |
Phosphoinositides as second messenger for shear stress transduction |
20, 22, 260 |
Intracellular Ca2+ rise; Ca2+ oscillations |
LSS; 0.2–4.0 dyn/cm2 | BAEC; 15–40 s | Ca2+ as second messenger | 7, 106, 332, 339 |
Flow modulation of effects of vasoactive agonists ATP and bradykinin |
LSS; 0–30 dyn/cm2 | BAEC; s | Indirect stimulation via agonist receptor mechanisms |
82, 83, 239, 261, 341 |
cGMP increased 3-fold via a NO- dependent mechanism; endothelial K+ channel implicated |
LSS; 0–40 dyn/cm2 | BAEC; 60 s | Vasoregulation mechanisms | 264 |
Transient elevation of IP3 | Cyclic strain; 24% deformation; 1 Hz |
HSVEC | Phosphoinositides as second messengers for strain deformation |
293, 310 |
Sustained PGI2 release; G proteins implicated |
LSS; 0–9 and 14.0 dyn/cm2 | HUVEC; 2 min | PGI2 regulation of vascular tone | 19, 95 |
Pulsed PGI2 release at higher level than steady flow |
LSS (pulsatile); mean 10 dyn/ cm2 |
HUVEC; <1 min | Antithrombotic properties | 118 |
Augmented factor Xa production (indicative of enhanced tissue factor activity) |
LSS; 0.7 and 2.7 dyn/cm2 | Activated HUVEC; min |
Enhanced procoagulant activity | 119 |
Vascular free radical generation | Perfusion rates 2–12 ml/min | Ex vivo artery; 10 min |
Unknown | 191 |
Stimulation of mitogen-activated protein kinases (MAPK); 35 dyn/ cm2 peak |
LSS; 3.5–117 dyn/cm2 | BAEC; 5 min, peak 20–30 min |
Involvement of membrane mitogen receptor-like pathway in shear transduction |
B. Berk, personal communication |
Activation of NFκB | LSS; 10 dyn/cm2 | BAEC; 20 min | Transcription factor activation | 186, 301 |
Induction of c-myc, jun | LSS; 10 dyn/cm2 | BAEC; 30 min | Immediate early growth response genes |
146, 186 |
Activation of adenylyl cyclase | Cyclic stretching; osmotic swelling |
BAEC, HUVEC; min | cAMP as second messenger for stretch |
192, 385 |
Directional remodeling of focal adhesion sites; Realignment with flow (>8 h) |
LSS; 10 dyn/cm2 | BAEC; min, h | Cell attachment site involvement in transmission and/or transduction of stress |
68, 304 |
Tension controls cell shape, pH, and growth via extracellular matrix- integrin binding |
Modulation of inherent cell tension |
Capillary EC; <1 h | Integrins regulate cell growth via cell tension |
156 |
Downregulation of VCAM-1 expression |
LSS; 0–7.2 dyn/cm2 | Mouse lymph node endothelial cells; >1 h |
Preferential leukocyte adhesion at low shear stress |
266, 321 |
10-Fold enhancement of PDGF-A mRNA; PDGF-A peak at 1.5–2 h |
LSS; 0–51 dyn/cm2 | HUVEC, BAEC; >1 h | Enhanced mitogen secretion; regulation of SMC growth |
147, 216, 238 |
2- to 3-fold increase of PDGF-B mRNA followed by 4-fold decrease by 9 h; PKC dependence controversial |
LSS; 10–36 dyn/cm2 steady, pulsatile, turbulent |
HUVEC, BAEC; 1–9 h | Identification of shear stress response element of PDGF-B gene |
147, 238, 301 |
bFGF mRNA stimulated 1.5- to 5-fold | LSS; 15 and 36 dyn/cm2 | BAEC; 0.5–9 h, peak at 6 h |
Peptide growth factor regulation |
216 |
Pinocytosis stimulated; adaptation by 6 h |
LSS; >5 dyn/cm2 | BAEC; <2 h | Plasma membrane vesicle formation rate transiently elevated |
61 |
Induction of c-fos; 50% block by PKC inhibitor |
LSS; 4–25 dyn/cm2 | BAEC; 1–2 h | Early growth response gene | 146, 148, 295 |
Increased TGF-β1 mRNA and biologically active TGF protein |
LSS; 20 dyn/cm2 | BAEC; 2 h | Inhibition of smooth muscle growth |
265 |
Upregulation of ICAM-1 mRNA and protein and enhanced lymphocyte adhesion; downregulated by 6 h |
LSS; 2.5–46 dyn/cm2 | HUVEC; 2 h | Enhanced binding of LFA-1- positive cells |
249, 321 |
Stimulation of IL-6 secretion and gene expression |
LSS; >10 dyn/cm2 | HUVEC; 2 h | Cytokine secretion | 223 |
Redistribution of Golgi apparatus and MTOC to upstream location in cell; normalized by 24 h |
LSS; 22 and 88 dyn/cm2 | BCAEC; >2 h | Temporary displacement of organelles |
47 |
Induction of protein kinase C | LSS; >10 dyn/cm2 | BAEC; <3 h | Regulation of protein phosphorylation |
181 |
Endothelin mRNA and protein secretion reported to be both stimulated and downregulated; mechanism appears to involve filamentous actin and microtubules |
LSS; 5–20 dyn/cm2 | PAEC and BAEC; peak at 2–6 h |
Regulation of vasoconstriction |
214, 215, 243, 338, 398 |
NO synthase mRNA and protein stimulated |
LSS; 15 dyn/cm2; flow through microcarrier bed; 0.5–2.0 ml/min |
BAEC; 3 h | Vasorelaxation |
182, 258, 285, 375, 376 |
HSP 70 mRNA increased 2- to 4-fold | LSS; bidirectional | BAEC; 4 h | HSP 70 shock response to flow | 139 |
tPA mRNA expression and secretion stimulated |
LSS; 15 and 25 dyn/cm2 | HUVEC; 5 h | Enhancement of fibrinolytic activity |
79–81 |
Cell proliferation in quiescent monolayer |
Turbulent flow; average shear stress 1.5–15.0 dyn/cm2 |
BAEC; >3 h | Loss of contact inhibition of growth by disturbed flow |
63 |
Cell alignment in direction of flow; function of time and magnitude of shear stress |
LSS; >5 dyn/cm2 | All types; >6 h | Minimizes drag on cell |
78, 85, 187, 193, 194 |
F-actin cytoskeletal and fibronectin rearrangement |
LSS; >5 dyn/cm2 and in vivo | All types; >6 h | Associated with cell realignment |
78, 97, 169, 189, 274, 388, 389 |
Differential cell shape and alignment responses; corresponding F-actin changes |
LSS; pulsatile 1 Hz; sinusoidal flows of various patterns up to 60 dyn/cm2 |
BAEC; >6 h | Discrimination between different types of pulsatile flows |
133, 134, 254, 255 |
Cell realignment perpendicular to strain; protein synthesis increased; F-actin redistribution perpendicular to strain |
Cyclic biaxial deformation; 0.78–12%; 1-Hz frequency 20–24% strain; 0.9–1.0 Hz |
BPAEC; >7 h HUVEC, HSVEC; 15 min |
Stretching of artery by blood pulsation; separation of strain and shear stress effects |
152, 343, 358 |
Histamine release and histamine decarboxylase activity stimulated |
Oscillatory LSS; range, 1.6–8.2 dyn/cm2 |
BAEC; >6 h | Modulation of endothelial permeability barrier |
348 |
Decreased thrombomodulin mRNA and protein at 15 and 36 dyn/cm2 |
LSS; 4, 15, and 36 dyn/cm2 | BAEC; 9 h | Protective role against thrombosis in regions of low shear stress |
217 |
Increased thrombomodulin activity (synthesis of activated protein C) |
LSS; 25 dyn/cm2 | HUVEC; 24 h | Protective in regions of higher shear stress |
321 |
Downregulation of fibronectin synthesis |
LSS; 24 dyn/cm2 + 20 mmHg hydrostatic pressure |
HUVEC; 12 and 48 h | Altered cell adhesion; platelet- endothelial interactions |
124 |
Regional cell cycle stimulation in confluent monolayer |
Disturbed laminar flow (flow separation, vortex, reattachment); 0–10 dyn/cm2 |
BAEC; 12 h | Steep shear gradients stimulate cell turnover; focal hemodynamic effects |
76 |
Reorganized topography of luminal surface at subcellular resolution |
LSS; 12 dyn/cm2 | BAEC; 24 h | Reduced gradients of shear stress in aligned cells; force transmission altered |
15, 16, 395 |
Mechanical stiffness of cell surface proportional to extent of realignment to flow |
LSS; 10–85 dyn/cm2 | BAEC; 24 h | Decreased deformability of subplasma membrane cortical complex |
323 |
LDL metabolism stimulated | LSS; 30 and 60 dyn/cm2 | BAEC; 24 h | Endothelial cholesterol balance | 351 |
Increase in class I and induction of class II MHC antigen expression |
LSS; 3–36 dyn/cm2 | Fat, omentum, and brain microvessels; 24–36 h |
Role of flow in immune response |
221 |
Inhibition of endothelial cell division | LSS | BAEC; 24–48 h | Regulation of endothelial regeneration |
407 |
Inhibition of collagen synthesis and stimulation of cell growth |
Cyclic biaxial stretch; 3 cycles/ min; 24% deformation |
BAEC, myocytes; 5 days |
Inverse relationship related to endothelial repair mechanisms |
359 |
LSS, laminar shear stress; BAEC, bovine aortic endothelial cells; Vm, membrane potential; BPAEC, bovine pulmonary artery endothelial cells; PAEC, porcine aortic endothelial cells; BCAEC, bovine carotid artery endothelial cells; IP3, inositol trisphosphate; HUVEC, human umbilical vein endothelial cells; HAEC, human aortic endothelial cells; PGI2, prostaglandin I2 (prostacyclin); tPA, tissue plasminogen activator; NO, nitric oxide; AA, arachidonic acid; PLA2, phospholipase A2; PDGF-A, PDGF-B, platelet-derived growth factor A and B chains, respectively; SMC, vascular smooth muscle cells; HSVEC, human saphenous vein endothelial cells; MTOC, microtubule organizing center; LDL, low-density lipoproteins; MHC, major histocompatibility complex; HSP 70, 70-kDa heat-shock protein.